Browsing by Subject "Alzheimer's disease"
Now showing items 1-7 of 7
-
Exploring Alzheimer's disease prediction with XAI in various neural network models
(Brac University, 2021-10)Using a number of Neural Network Models, we attempt to explore and explain the prediction of Alzheimer's in patients in various stages of the disease, using MRI imaging data. Alzheimer's disease(AD) often described as ... -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
(Brac University, 2023-10)Alzheimer’s disease is a neurodegenerative disease. Using FDA Adverse Event Reporting System database, a pharmacovigilance study for gender specific rhabdomyolysis risk in memantine users was conducted between January ... -
Mini-mental state examination in hospitalized post COVID-19 patient to identify the risk of AlzheiMer`s development
(Brac University, 2023-02)SARS Covid-19 has affected 6 million people in 2020 to 2022. The primary difficulty the patient faces respiratory difficulty. But the virus affects several peripheral systems as well. Central nervous system is one of the ... -
Multi-classification based Alzheimer's disease detection with comparative analysis from brain MRI scans using deep learning
(Brac University, 2021-10)The neurodegenerative Alzheimer's Disease is the most widely recognized cause of `Dementia' and was allegedly the 7th highest cause of death globally. Nevertheless, there is still no conclusive test for distinguishing ... -
A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
(Brac University, 2023-10)The study employed the Food and Drug Administration Adverse Event Reporting System (FAERS) database to study the impact of Rivastigmine, an acetylcholinesterase inhibitor (AChI), on patient mortality. The study determines ... -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
(Brac University, 2023-02)Galantamine is one of the common acetylcholinesterase inhibitors used to treat Alzheimer's disease, a neurodegenerative disorder. This study was conducted to determine the impact of galantamine on mortality rate and ... -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
(Brac University, 2023-02)The following study utilized the Food and Drug Administration Adverse Event Reporting System (FAERS) database to determine the AChI inhibitor, rivastigmine’s effect on patient mortality as well as its side effect of ...
